Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025)
Siga Technologies (SIGA) posted Other Non-Current Liabilities of $2.7 million for Q4 2025, down 19.15% on a QoQ basis from $3.3 million in Q3 2025, and down 17.1% year-over-year from $3.2 million in Q4 2024.
Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
Siga Technologies' Other Non-Current Liabilities history runs 15 years deep, the most recent figure standing at $2.7 million for Q4 2025.
- Quarterly Other Non-Current Liabilities fell 17.1% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (down 17.1% YoY) and the FY2025 annual result came in at $2.7 million, down 17.1% from the prior year.
- Other Non-Current Liabilities was $2.7 million for Q4 2025 at Siga Technologies, down from $3.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $6.5 million in Q4 2021 and bottomed at $2.7 million in Q4 2025.
- A 5-year average of $3.5 million and a median of $3.4 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Peak annual rise in Other Non-Current Liabilities reached 123.69% in 2021, while the deepest fall reached 53.53% in 2021.
- Siga Technologies' Other Non-Current Liabilities stood at $6.5 million in 2021, then sank by 48.51% to $3.4 million in 2022, then rose by 0.54% to $3.4 million in 2023, then slipped by 5.2% to $3.2 million in 2024, then retreated by 17.1% to $2.7 million in 2025.
- Business Quant data shows SIGA's Other Non-Current Liabilities at $2.7 million in Q4 2025, $3.3 million in Q3 2025, and $3.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 3.40 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 3.72 Mn |
| Jun 30, 2021 | 3.72 Mn |
| Mar 31, 2021 | 2.85 Mn |
| Dec 31, 2020 | 2.92 Mn |